Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoMTA vs White MTA in Revascularization of Immature Teeth
NCT03545139Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
Phase 1, randomised trial (2 arms), sponsored by Cairo University. Primary endpoint: Discoloration/ Staining potential at 9 months. Status: unknown.
Beyond the preview
Go deeper on NCT03545139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03545139.